Literature DB >> 6608435

The painful stump neuroma and its treatment.

H B Williams.   

Abstract

Successful clinical management of symptomatic neuromas continues to present a challenge to the responsible surgeon. It is unexplained why some patients with neuromas are completely asymptomatic while others exhibit debilitating symptoms. Prevention of neuromas is paramount with precise attention to severed nerves following amputations and other surgical procedures. Once established, treatment of neuromas consists of careful patient counseling, local massage, and desensitization procedures. Sympathetic blockade with guanethidine may be beneficial in some patients. When necessary, surgical excision of the neuroma along with a combination of funiculectomy, epineurial sleeve suture ligation, and silicone capping offers the best chance for eradication. In intractable or recurrent cases and following careful patient selection, neuroma excision followed by nerve grafting combined with sympathetic blockade using guanethidine can be successful in a significant number of cases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608435

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  4 in total

1.  Effects of retrograde axonal transport of Ricinus communis agglutinin I on neuroma formation.

Authors:  I Nennesmo; K Kristensson
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Sciatic neuroma presenting forty years after above-knee amputation.

Authors:  M Kitcat; J E Hunter; C M Malata
Journal:  Open Orthop J       Date:  2009-12-30

3.  Role of Nd:YAG laser for prevention of neuroma formation: an in vivo experimental study.

Authors:  Tarek F Elwakil; Ahmad Elkharbotly
Journal:  Lasers Med Sci       Date:  2007-05-12       Impact factor: 3.161

4.  Mechanisms of nerve capping technique in prevention of painful neuroma formation.

Authors:  Hede Yan; Feng Zhang; Jon Kolkin; Chunyang Wang; Zhen Xia; Cunyi Fan
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.